A. Chugh

发表

Squalene epoxidase as hypocholesterolemic drug target revisited.

A. Chugh, A. Ray, J. Gupta, 2003, Progress in lipid research.

Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease

Ashok P. Giri, Sneha B. Bansode, Mahesh J. Kulkarni, 2020, Journal of biomolecular structure & dynamics.

Benign prostatic hyperplasia: an insight into current investigational medical therapies

A. Chugh, A. Tiwari, N. S. Krishna, 2005, Expert opinion on investigational drugs.

Discovery of a potent and selective small molecule hGPR91 antagonist.

A. Chugh, J. Vacca, D. Cully, 2011, Bioorganic & medicinal chemistry letters.

Modulation of Dopamine Receptor Agonist-Induced Rotational Behavior in 6-OHDA-Lesioned Rats by a Peptidomimetic Analogue of Pro-Leu-Gly-NH2 (PLG)

A. Chugh, E. R. Marcotte, R. Mishra, 1997, Peptides.

A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives.

G. Bedse, S. Menon, A. Chugh, 2017, European journal of medicinal chemistry.

Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice

A. Chugh, E. R. Marcotte, R. Mishra, 2001, Neuroscience Letters.

RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.

A. Chugh, A. Ray, A. Patra, 2011, European journal of pharmacology.

Discovery of liver-directed glucokinase activator having anti-hyperglycemic effect without hypoglycemia.

A. Chugh, V. Jain, K. Mookhtiar, 2017, European journal of medicinal chemistry.

Protection Against MPTP Treatment by an Analog of Pro-Leu-Gly-NH2 (PLG, MIF-1)

A. Chugh, E. R. Marcotte, R. Mishra, 1998, Peptides.

Development of neurogenic pulmonary edema at different grades of intracranial pressure in cats.

A. Chugh, Y. Gupta, V. Mehta, 1998, Indian journal of physiology and pharmacology.

High Level Stable Expression of Pharmacologically Active Human M1–M5 Muscarinic Receptor Subtypes in Mammalian Cells

A. Chugh, S. Khattar, K. Saini, 2005, Biotechnology Letters.

Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.

A. Chugh, J. Vacca, D. Barawkar, 2012, Bioorganic & medicinal chemistry letters.

Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors.

A. Chugh, J. A. Davis, V. Bansal, 2008, Bioorganic & medicinal chemistry letters.

Discovery of Potent and Selective A2A Antagonists with Efficacy in Animal Models of Parkinson's Disease and Depression.

A. Chugh, S. Chaudhary, D. Barawkar, 2017, ACS medicinal chemistry letters.

Statins and myotoxicity: a therapeutic limitation

A. Chugh, A. Tiwari, K. Mookhtiar, 2006, Expert opinion on drug safety.

Synthesis and optimization of novel and selective muscarinic M3 receptor antagonists

A. Chugh, Kirandeep Kaur, Suman Gupta, 2007 .

Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.

A. Chugh, A. Ray, J. Gupta, 2007, European journal of pharmacology.

Opposing effect of apomorphine on antinociceptive activityfx of morphine: a dose-dependent phenomenon

A. Chugh, Y. Gupta, S. Seth, 1989, Pain.

Intermittent claudication: an overview.

A. Chugh, B. Thyagarajan, S. Mittra, 2006, Atherosclerosis.

Role of peripheral 5-HT1A receptors in detrusor over activity associated with partial bladder outlet obstruction in female rats.

A. Chugh, Shivani Mittra, Shivani Malhotra, 2007, European journal of pharmacology.

Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A1 receptor antagonists and their biological evaluation.

G. Bedse, S. Menon, A. Chugh, 2017, Bioorganic & medicinal chemistry.

Antiviral drugs prioritization for COVID-19 management based on rational selection

A. Chugh, R. Joshi, A. Giri, 2021, Current Science.

Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.

A. Chugh, S. Chaudhary, J. Vacca, 2011, ACS medicinal chemistry letters.

RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.

A. Chugh, A. Ray, J. Gupta, 2009, European journal of pharmacology.

Molecular cloning, stable expression and cellular localization of human α1-adrenergic receptor subtypes: effect of charcoal/dextran treated serum on expression and localization of α1D-adrenergic receptor

A. Chugh, A. Gautam, A. Tiwari, 2006, Biotechnology Letters.

Modulation of morphine induced antinociception by intracerebroventricularly administered captopril.

A. Chugh, Y. Gupta, S. Arora, 1991, Indian journal of experimental biology.

AE9C90CB: a novel, bladder‐selective muscarinic receptor antagonist for the treatment of overactive bladder

A. Chugh, A. Ray, V. Bansal, 2010, British journal of pharmacology.

RESEARCH PAPER AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder

A. Chugh, A. Ray, Suman Gupta, 2010 .

Design and synthesis of novel xanthine derivatives as potent and selective A2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases.

S. Menon, A. Chugh, V. Karande, 2017, European journal of medicinal chemistry.

Modulation ofN-methyl-d-aspartate (NMDA) antagonist-induced darting behaviour by the peptidomimetic PAMTA

A. Chugh, R. Mishra, R. Johnson, 1995, Brain Research.

Role of endogenous opioids and histamine in morphine induced emesis.

A. Chugh, Y. Gupta, P. Bhandari, 1989, Indian journal of experimental biology.

A Comprehensive Molecular and Clinical Investigation of Approved Anti-HCV Drugs Repurposing against SARS-CoV-2 Infection: A Glaring Gap between Benchside and Bedside Medicine

A. Chugh, Meenakshi B. Tellis, R. Joshi, 2023, Vaccines.

Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.

A. Chugh, J. Vacca, D. Barawkar, 2012, Bioorganic & medicinal chemistry letters.